“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...

The global sales of attenuated vaccines are projected to soar, with an estimated worth of USD 5,068.2 million in 2024 and anticipated to reach USD 9,693.9 million by 2034. This growth trajectory ...

Influenza A is the most common variant of the flu and the one you’re most likely to get during pregnancy. A flu shot is the ...

AuraVax Therapeutics, Inc., a company developing novel immunotherapies to prevent and treat respiratory pathogens, today announced it has been awarded a preclinical research contract with the Division ...

Moreover, flu viruses are constantly changing. This is why flu vaccines are updated routinely, with new vaccines developed that contain influenza viruses that match circulating strains. The flu ...

Right now, only healthcare providers can administer the spray. So, exactly what is FluMist? It is a live influenza vaccine containing a weakened flu virus for the three prominent vaccine strains. It’s ...

The Oxford AstraZeneca vaccine is credited with saving millions of lives but it was also responsible, in rare cases, for serious side-effects - blood clots in the brain - which could be fatal.

The report looked both at available vaccines and vaccines in development. An international panel of vaccine experts classified the vaccines by how feasible they are to develop and implement and ...

SALEM, Ore. (KTVZ) -- The U.S. Department of Agriculture’s Animal Plant Health Inspection Service confirmed on Friday the presence of highly pathogenic avian influenza in a backyard flock in ...